Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Apr 14;15(2):282-292.
doi: 10.3390/pediatric15020024.

Intravesical Agents in the Treatment of Bladder Clots in Children

Marcello Della Corte  1   2 , Erica Clemente  3 , Elisa Cerchia  2 , Sabrina De Cillis  1 , Enrico Checcucci  1 , Daniele Amparore  1 , Cristian Fiori  1 , Francesco Porpiglia  1 , Simona Gerocarni Nappo  2
Affiliations
Review

Intravesical Agents in the Treatment of Bladder Clots in Children

Marcello Della Corte et al. Pediatr Rep. .

Abstract

Bladder blood clots represent an infrequent urinary condition in children. They usually result from hematuria with many underlying causes, such as urinary tract infections and urethral/bladder traumas. Treatment options for clot removal include trans-urethral or suprapubic bladder irrigation and, if unsuccessful, endoscopic management under general anesthesia with a resectoscope. In younger male children, however, the repeated passage of a trans-urethral resectoscope may be challenging and traumatic, due to the small lumen diameter. Eventually, an open surgical approach can be required in many patients. Few anecdotal non-surgical approaches have been proposed for the management of bladder blood clots in children. This review aims to summarize the conservative techniques described in the literature with the instillation of intravesical agents, analyzing the different strategies and their advantages.

Keywords: bladder clots; bladder instillation; blood clots; children; endocavitary; intravesical agents; pediatric urology.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Flow chart of clinical assessment and management of bladder clots.
Scheme 1
Scheme 1
Synthesis of all the advantages of intravesical agents use for bladder clot evacuation.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Greenfield S.P., Williot P., Kaplan D. Gross Hematuria in Children: A Ten-Year Review. Urology. 2007;69:166–169. doi: 10.1016/j.urology.2006.10.018. - DOI - PubMed
    1. Olarte J.L., Glover M.L., Totapally B.R. The Use of Alteplase for the Resolution of an Intravesical Clot in a Neonate Receiving Extracorporeal Membrane Oxygenation. ASAIO J. 2001;47:565–568. doi: 10.1097/00002480-200109000-00034. - DOI - PubMed
    1. Gander R., Asensio M., Guillén G., Royo G.F., Bolaños A., Pérez M., Diaz-De-Heredia C., Benitez M., López M. Hemorrhagic Cystitis after Hematopoietic Stem Cell Transplantation: A Challenge for the Pediatric Urologist. J. Pediatr. Urol. 2018;14:366–373. doi: 10.1016/j.jpurol.2018.03.018. - DOI - PubMed
    1. Bo J., Yangyang Y., Jiayuan L., Siwen D., Yong C., Junbo Y. Evaluation of Bladder Clots Using a Nonsurgical Treatment. Urology. 2014;83:498–499. doi: 10.1016/j.urology.2013.09.022. - DOI - PubMed
    1. Horváth O., Szabó A.J., Reusz G.S. How to Define and Assess the Clinically Significant Causes of Hematuria in Childhood. Pediatr. Nephrol. 2022:1–14. doi: 10.1007/s00467-022-05746-4. - DOI - PMC - PubMed

LinkOut - more resources